Vaping and Smoking Project in People With Schizophrenia

The proposed research will characterize withdrawal among people with schizophrenia who vape daily compared to people with schizophrenia who smoke combustible cigarettes daily, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence and contributing to the development of vaping cessation interventions amongst people with schizophrenia, the leading preventable cause of death in the US.

NCT Number	NCT06944847
Lead Sponsor	State University of New York at Buffalo Collaborators: Roswell Park Cancer Institute, National Institute on Drug Abuse (NIDA)
Conditions	Acute Abstinence From Cigarettes vs E-cigarettes (ENDS)
Enrollment	64 participants
Start Date	2025-02-15
Primary Completion	2027-04-01 (estimated)
Study Completion	2027-04-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-09